Paracrine-mediated pathways modulated by human allogeneic dental follicle stem cells

Paracrine-mediated pathways modulated by human allogeneic dental follicle stem cells (DFSCs) refer to the complex signaling networks activated by the secretome of these mesenchymal stem cells (Frontiers in Cell and Developmental Biology, 2021). DFSCs, derived from the dental follicle of impacted teeth, release a variety of bioactive molecules including growth factors such as BMP-2, TGF-beta, and VEGF, as well as various cytokines and extracellular vesicles (PubMed, PMID: 31452654). These factors act on neighboring cells to regulate critical biological processes such as osteogenic differentiation, angiogenesis, and immunomodulation (International Journal of Molecular Sciences, 2020). In disease contexts, these pathways are primarily explored for their role in treating periodontal defects, alveolar bone loss, and inflammatory conditions by creating a pro-regenerative microenvironment (Journal of Periodontology, 2019). While not a single molecular target, the modulation of these pathways represents a therapeutic strategy in regenerative medicine that avoids the complexities of direct cell engraftment. Safety concerns associated with these pathways include the risk of ectopic tissue formation and the challenge of maintaining secretome consistency across different cell donors (Stem Cell Research & Therapy, 2022).

Other names

DFSC paracrine signalingDental follicle stem cell secretome-mediated pathwaysDFSC-modulated regenerative pathways

Modulation of the local cellular microenvironment through the secretion of bioactive factors (growth factors, cytokines, and extracellular vesicles) that activate regenerative signaling cascades in recipient cells.